Anuh Pharma stocks up 16.54% as it gets approval from regulators ANSM and WHO

Anuh Pharma Ltd has informed BSE that it has got approval for Erythromycin Ethyl Succinate and Pyrazinamide by French Naional Agency for Medicines and Health Products Safety (ANSM).

Dec 16, 2016 06:12 IST India Infoline News Service

Anuh Pharma Ltd ended at Rs 238.55, up by Rs 33.85 or 16.54% from its previous closing of Rs 204.7 on the BSE.

Anuh Pharma Ltd
has informed BSE that it has got approval for Erythromycin Ethyl Succinate and Pyrazinamide following inspection of manufacturing site of Anuh Pharma Ltd on September 16, 2016 by French Naional Agency for Medicines and Health Products Safety (ANSM).

Also, the company got an approval for Pyrazinamide APIMF158 and Sulfadoxine APIMF234 following inspection on September 16, 2016 by World Health Organisation (WHO) Geneva, an official statement added.

The scrip opened at Rs 208.35 and touched a high and low of Rs 245 and Rs 208.35 respectively. A total of 188641(NSE+BSE) shares were traded on the counter. The current market cap of the company is Rs 512.9 crore.

The BSE group 'XC' stock of face value Rs 5 touched a 52 week high of Rs 344 on 21-Dec-2015 and a 52 week low of Rs 159 on 21-Apr-2016. Last one week high and low of the scrip stood at Rs 217.05 and Rs 201.1 respectively.

The promoters holding in the company stood at 71.15 % while Institutions and Non-Institutions held 0.31 % and 28.54 % respectively.

The stock traded above its 50 DMA.

Related Story

Open Free Demat Account (Rs699)